Daeryun Law Firm signed an MOU for medical legal advice with Hyple Co., Ltd.

Daeryun plans to provide legal advice to executives and employees, international transaction legal advice, and in-house personnel and labor advice.
Manage major legal issues including the Fair Trade Act, Labor Standards Act, and Occupational Safety and Health Act
Daeryun CEO Kim Kuk-il “We will continue to discuss pending issues with HIFLE… We will achieve win-win development.”

Daeryun Law Firm (Limited) announced that it has signed a legal advisory MOU with Hiple Co., Ltd. for mutual growth.

On the 11th, Daeryun announced on the 7th that the agreement ceremony held at KDB Life Tower, its headquarters in Seoul, was attended by Daeryun's CEO Kim Kuk-il, Chief General Counsel Won Hyeong-il, and Hiple Co., Ltd. CEO Cho Jae-min.

Hiple Co., Ltd. is a leading company in the field of raw drug products that engages in pharmaceutical wholesale business. We supply raw materials to domestic and foreign pharmaceutical companies through pharmaceutical research and development, manufacturing, and distribution.

Through this agreement, Daeryun supports ▲ legal consultation for executives and employees, ▲ legal advice on international transactions, ▲ review of certification and patents, ▲ internal personnel and labor advice, and ▲ representation in civil and criminal litigation.

In addition, Daeryun plans to provide three-dimensional and comprehensive legal advice by utilizing specialized groups in each field, including medical care, corporate law, intellectual property rights, fair trade, customs, and international trade.

In addition, we plan to manage major legal issues such as the Fair Trade Act, Labor Standards Act, and Occupational Safety and Health Act, and review whether local laws related to overseas investment are violated.

Daeryun Won-il, chief general counsel, said, "Continuous issues such as fair trade and major disasters are emerging, so we will provide focused legal advice and support on these issues. We will help Hiple, which is engaged in international contracts and overseas investments, grow into a global company."

Hiple CEO Cho Jae-min said, “Domestic pharmaceutical regulations are so severe that they can be considered a collection of regulations from developed countries in the United States, Japan, and Europe. It is in the pharmaceutical industry that problems such as deviations in various processes are more common than in other jobs,” and emphasized, “With Daeryun’s legal support, we expect to increase work efficiency in areas such as fair trade, overlapping trade regulations, and strategic planning for restructuring after the acquisition of Dongindang Pharmaceutical.”

CEO Kim Kook-il of Daeryun said, “Daeryun’s medical specialty group can respond quickly to drug-related incidents and accidents. In particular, we also operate various professional groups, including civil and criminal, that can flexibly resolve linked cases,” and expressed his ambition, “We will continue to discuss pending issues that arise in the field with Hyple and the expansion of the corporate consulting field to achieve win-win development.”

[View full article] 

Dailyan -Daeryun Law Firm signs medical legal advisory MOU with Hyple Co., Ltd.

Laportian -Daeryun Law Firm and Hyple enter into a business agreement for ‘medical legal advice’